| Immunology - Enhance your understanding of the immune status |
|
|
|
|
| |
|
| |
The latest immunology news from News Medical |
|
|
|
 | | |
 Immune Checkpoints as Potential Targets in Cutaneous Leishmaniasis
In this interview, Dr. Nidhi S. Dey, University of York, presents her exciting new work on the spatial analysis of IDO1 and PDL1 checkpoints in cutaneous leishmaniasis. The shown study focuses on uncovering potential targets, also known as immune checkpoints, for the treatment strategy of the major neglected parasitic disease, leishmaniasis.
| |
|
|
|
|
|
 | | |  Immunosenescence can occur in the elderly or aging population and involves a decrease in many immune functions, which leads to the immune system having reduced efficacy when responding to infections or vaccines. | | | | |  The immunogenicity, safety, and effectiveness of ARPV/ZIKV a chimeric insect-specific flavivirus (ISFV)-Zika vaccine. | | | | |  The impact of nicotinamide mononucleotide (NMN) on Clusters of differentiation 4+ (CD4+ ) Thymus cells (T cells) viz. | | | | |  T cells are the key immune system component involved in killing cancer. Tumors produce signals that turn off these T cells, partially by forcing them to progressively differentiate (mature) into a hypofunctional state known as exhaustion. | |
|
|
|
| | How would you rate today's newsletter?
| |
|
|
|
|
|
